When mesothelial cells become transformed in an HMGB1-rich environment, most of the resulting MM cells require HMGB1 to grow and to invade nearby tissues; accordingly, abrogation of HMGB1 function may have therapeutic efficacy10. This evidence concerns the gene HMGB1 and Miyoshi myopathy.